- Home
- GHRS vs KBDC Comparison
GHRS vs KBDC Comparison
Compare GHRS & KBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GHRS | KBDC |
|---|---|---|
| Founded | 2018 | 2021 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 892.0M | 1.1B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | GHRS | KBDC |
|---|---|---|
| Price | $13.30 | $14.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $30.11 | $15.80 |
| AVG Volume (30 Days) | 233.2K | ★ 423.5K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | ★ 13.27% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $193.84 |
| Revenue Next Year | N/A | $9.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.95 | $13.06 |
| 52 Week High | $20.50 | $17.99 |
Technical Indicators
Market Signals| Indicator | GHRS | KBDC |
|---|---|---|
| Relative Strength Index (RSI) | 49.62 | 34.18 |
| Support Level | $12.40 | $14.61 |
| Resistance Level | $13.33 | $14.91 |
| Average True Range (ATR) | 0.64 | 0.26 |
| MACD | -0.00 | -0.12 |
| Stochastic Oscillator | 54.35 | 9.28 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About KBDC Kayne Anderson BDC Inc.
Kayne Anderson BDC Inc is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company that invests primarily in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through debt investments in middle-market companies.